|Year : 2021 | Volume
| Issue : 1 | Page : 46-52
Effect of menopause on arterial stiffness and central hemodynamics: A pulse wave analysis-based cross-sectional study from Gujarat, India
Jayesh Dalpatbhai Solanki1, Devanshi Nishantbhai Bhatt2, Ravi Kanubhai Patel2, Hemant B Mehta1, Chinmay J Shah1
1 Department of Physiology, Government Medical College, Bhavnagar, Gujarat, India
2 Government Medical College, Bhavnagar, Gujarat, India
|Date of Submission||11-Aug-2020|
|Date of Decision||21-Nov-2020|
|Date of Acceptance||21-Nov-2020|
|Date of Web Publication||17-Apr-2021|
Jayesh Dalpatbhai Solanki
Department of Physiology, Government Medical College, Bhavnagar, Behind ST Bus Stand, Jail Road, Bhavnagar - 364 001, Gujarat
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Menopause, a cardiovascular risk in mid-life women, is studied in terms of blood pressure mostly. Arterial stiffness (AS) and central hemodynamics (CH) are direct surrogates measured by pulse wave analysis (PWA) with no study from our region. Objective: We studied AS, CH in relation to menopause using PWA. Materials and Methods: A cross-sectional study was performed in 134 middle-aged females divided into groups with or without menopause. Oscillometric PWA done by Mobil-o-Graph (IEM, Germany) gave – AS like augmentation pressure, augmentation index at heart rate (HR) 75, aortic pulse wave velocity (aPWV), and total AS pulse pressure amplification; CH like aortic blood pressure, cardiac output and related parameters, peripheral resistance, stroke work, prevalent brachial/central hypertension, and raised central pulse pressure. They were further compared between groups, in relation to body mass index (BMI) and by multiple regressions with P < 0.05 as statistical significance. Results: Postmenopausal women were significantly elder, physically inactive with comparable BMI and showed higher AS (only aPWV was significantly different) and CH. BMI was unrelated to AS or CH in postmenopausal group. Age (except for aPWV), BMI, and HR (except for [email protected]) were insignificant predictors, while systolic blood pressure (SBP) in premenopausal and diastolic blood pressure (DBP) in postmenopausal group was major AS predictors. Age, HR, and BMI were insignificant predictors, while SBP more than DBP was significant predictors of CH. Conclusions: In obese, predominantly sedentary midlife Gujarati women, menopause negatively affects AS and hemodynamics, central more than peripheral. Menopause accelerates cardiovascular aging, independent of BMI, and age that calls for further studies.
Keywords: Aging, arterial stiffness, blood pressure, cardiac output, hemodynamics, menopause, oscillometry, pulse wave analysis, pulse wave velocity
|How to cite this article:|
Solanki JD, Bhatt DN, Patel RK, Mehta HB, Shah CJ. Effect of menopause on arterial stiffness and central hemodynamics: A pulse wave analysis-based cross-sectional study from Gujarat, India. J Mid-life Health 2021;12:46-52
|How to cite this URL:|
Solanki JD, Bhatt DN, Patel RK, Mehta HB, Shah CJ. Effect of menopause on arterial stiffness and central hemodynamics: A pulse wave analysis-based cross-sectional study from Gujarat, India. J Mid-life Health [serial online] 2021 [cited 2022 Oct 4];12:46-52. Available from: https://www.jmidlifehealth.org/text.asp?2021/12/1/46/313976
| Introduction|| |
Menopause is a physiological factor affecting cardiovascular health in mid-life women. It is studied mainly in terms of blood pressure, which has its limitations, while central hemodynamics (CH) are direct surrogates of cardiovascular function. Arterial stiffness (AS) is affected early in cardiovascular aging and before incident hypertension. These AS and CH parameters, though proved more direct and discrete, are reported scarcely. Pulse wave analysis (PWA) provides noninvasive measurement of the same. In Mobil-o-graph-based PWA normative studies, of these parameters in our population, a male disadvantage was found that turns to female disadvantage after middle age. Menopause could be one contributor responsible for the same and AS, CH parameters could be different. Hence, we studied effect of menopause on AS, CH parameters using same protocol and instrument.
| Materials and Methods|| |
Study setting and study participants
A cross-sectional field study was conducted by physiology department of a government medical college between January and June 2019. Research protocol was first approved by the institutional review board numbered IRB (HEC) 865/2019; dated 01/06/2019. Sample size was calculated using Raosoft software (Raosoft, Inc., free online software, Seattle, WA, USA). To yield 95% confidence level and 5% precision, with response distribution 8% assumed for perimenopausal female age group, a sample size of 134 was adequate. Using convenience sampling, we enrolled 200 apparently healthy females from community.
Inclusion and exclusion criteria
We included apparently healthy nonathletic females, aged 40–60 years, with known menopausal status, nonaddicted, not known to report any acute or chronic disease, not using any medical treatment, willing for written informed consent. One participant was excluded from the study after pulse wave recording owing to irregular pulse rhythm. We had 67 postmenopausal females, and of remaining 133 we choose 67 with higher age. Hence, final sample size was 134 divided into two groups each with 67, differing by menopausal attainment.
Subject assessment and definitions
All participants were screened for study criteria, demographic characteristics, and relevant history.
Menopause was defined as self-reported absence of menstruation for at least 1 year.
Brachial hypertension was defined as brachial systolic blood pressure (SBP) ≥140 mmHg and diastolic blood pressure (DBP) ≥90 mmHg or use of antihypertensive medication.
Central hypertension was defined as aortic SBP ≥130 mmHg and DBP ≥90 mmHg.
Central pulse pressure ≥40 mmHg was considered as abnormal.
Instrument used – Mobil-o-graph
We used portable, PC-attached calibrated, and validated instrument Mobil-o-Graph (IEM Gmbh, Stolberg, Germany) owned by physiology department to record brachial pulse wave. It contained three different sized arm cuffs, connecting tube, recorder, bluetooth, licensed software, and laptop. It performs PWA based on oscillometric principle and analysis of pressure pulse wave. First mid-arm circumference of the left arm is measured to choose the BP cuff of appropriate size-small (20–24 cm), medium (24–32 cm), or large (32–38 cm). It is wrapped around the left arm and tubing is connected to the recorder device as per standard protocol. As per ARCSolver algorithm, a recording device generates pressure in the cuff by self-inflation, and deflation follows it in stepwise manner. If first reading is free of artifact and error, there is a pause of 30 s to follow, after which there is second inflation–deflation. During deflation, the cuff is kept inflated at brachial diastolic pressure for 10 s which allows intermittent flow that produces pressure pulse waves. Brachial arterial pulsation generates the pressure oscillations which are transmitted to blood pressure cuff tied around the left arm and measured by transducer to be fed into microprocessor. Computerized software records pulse wave of brachial artery and by validated a generalized transfer factor derives central aortic pulse wave. It further undergoes point-based and area-based analysis by computer to derive various cardiovascular parameters.
It is same as used for our previous normative studies:, a blood pressure cuff of appropriate size was chosen based on measured mid-arm circumference and applied to left arm using standard protocol. All readings were taken after 10 min of rest, in postabsorptive phase with participants avoiding smoking or alcohol for 12 h before the test, in a calm room avoiding external influences or arm movement. Measurements were taken twice in each participant. Owing to objective, algorithm-based, validated measurement protocol, there is good inter- or intra-observer reproducibility.
Parameters measured and derived
These are same as used by previous normative studies, and listed here:
- Heart rate (HR), body mass index (BMI), and body surface area (BSA)
- Brachial blood pressure (bBP) – systolic, diastolic, pulse, and mean
- Central blood pressure (cBP) – systolic (cSBP), diastolic, and pulse (cPP)
- Measured central hemodynamics – cardiac output (CO), cardiac index, and peripheral resistance (PR)
- Derived central hemodynamics
- Stroke volume (SV) – CO/HR
- SV index – SV/BSA
- Stroke work (SW) − (pulse pressure) × (SV) × 0.0144
Measured AS parameters
- Augmentation pressure
- Augmentation index at HR 75/min ([email protected])
- Reflection magnitude percent
- Aortic pulse wave velocity (aPWV).
Derived AS parameters
- Total AS = pulse pressure/SV
- Pulse pressure amplification = brachial to aortic pulse pressure.
Collected data were transferred to Excel Spreadsheet, and descriptive analysis was expressed as mean ± standard deviation until indicated specifically, while qualitative data were expressed as number (percentage). GraphPad InStat 3 software (demo version free software of GraphPad Software, Inc. California, USA) was used for statistical analysis. Comparison of numerical data was done by Mann–Whitney test or unpaired Student's t-test for two groups and by ANOVA test for more than two groups. Qualitative data were compared between groups by normality test. Multiple linear regressions were applied to find major and significant predictors of study parameters. Statistical significance level was set at P < 0.05.
| Results|| |
PWA-based parameters were compared between pre-menopausal and post-menopausal groups. Age was significantly higher in postmenopausal group, so as physical inactivity. BMI was comparable and mean was 27. Premenopausal group had higher values of brachial and aortic blood pressure with significance for all except DBP. HR and rate pressure product were comparable between groups. CO and related parameters, SW were raised significantly in postmenopausal group except PR. AS parameters were significantly raised in postmenopausal group than premenopausal group. However, statistical significance was evident only for aortic PWV [Table 1].
|Table 1: Compassion of baseline and study parameters between premenopausal and postmenopausal groups|
Click here to view
Postmenopausal participants were further subdivided into three subgroups based on BMI cutoff 25 and 30. With increase in BMI, all parameters increased across three groups. However, among CH, only HR, brachial PP, and SV index exhibit statistical significance. While among AS parameters, only total AS was significantly different between subgroups [Table 2].
|Table 2: Compassion of baseline and study parameters in three postmenopausal women subgroups based on body mass index cut off 25 and 30|
Click here to view
By multiple linear regression models, we evaluated predictors of AS and CH (dependent parameters) from independent parameters in both groups separately. BMI was not a significant predictor in either group so as age (except for cPP, cSBP in postmenopausal group). bBP was significant predictor in both groups, systolic more than diastolic. HR was a more significant exposure parameter in postmenopausal group than premenopausal. Pattern of predictors was same with few differences in two study groups. Age was significant positive predictor of only aortic PWV, while HR was a major positive predictor of [email protected] in either group. In premenopausal group, brachial SBP and in postmenopausal group brachial DBP were significant predictors of AS [Table 3] and [Table 4].
|Table 3: Association of dependant study parameters with cardiovascular disease risk factors (independent parameters) by multiple linear regressions (rpartial values) in premenopausal women|
Click here to view
|Table 4: Calculation of the predictors for dependant variables by multiple linear regressions (rpartial values) in postmenopausal women|
Click here to view
There was odds risk of 2.17, 2.71, and 2.04 in postmenopausal group than premenopausal group for prevalent brachial hypertension, central hypertension, and raised central pulse pressure, respectively. All odds ratios were statistically insignificant [Table 5].
|Table 5: Association of menopause with abnormal haemodynamics (odds ratio)|
Click here to view
| Discussion|| |
We have previously published normative studies, of CH and AS parameters based on oscillometric PWA. We observed that (1) there was male disadvantage for CH which lasted up to age group 45 and beyond that it was female disadvantage and (2) aPWV was higher in males from 15 to 44-year age group and higher in females from 45 to 65 years of age. Mean menopausal age in Indian women is reported to be 46 years. Hence, this female disadvantage compared to males from mid-40s was hypothesized to be due to menopause.
We found menopause as a significant factor affecting CH in middle-aged women, in line with studies done by others,, in the elderly Western population. Most Indian studies reaffirms accelerated hemodynamics with menopause but mainly with respect to bBPs., Our results underscores both brachial and aortic blood pressures, measured by specifically designed, calibrated, validated device based on oscillometric PWA. Another highlight is the comparison of CO and related parameters that is not reported in most Indian studies. Sherwood et al., in contrast to us, reported reduced CO and increased systemic vascular resistance in their menopausal population both at rest and during stress. Our result highlights the acceleration of CH that precedes hypertension. We have found similar female disadvantage in middle aged and elderly Type 2 diabetics, treated hypertensives and newly diagnosed hypertensives, and the same remains evident with normative menopause. Despite comparable HR and BMI, there was significantly higher cardiac workload as measured by SW. With menopause, altered sympathetic activity produces sustained hemodynamic load that is root cause for pathological structural and functional changes in blood vessels. It can lead to hypertension and heart failure, in years to come.
Among studied parameters, heart and large artery related parameters such as SBP, CO, and SV were significantly increased, while small artery parameters such as DBP and PR were not significantly affected. Age group of postmenopausal patient was 52, and this indicates that central hemodynamic is early affected. Blood pressure (sympathetic function) was augmented and HR (parasympathetic function) was comparable. This underscores that sympathetic overactivity is more than loss of vagal tone in early postmenopausal period, as mentioned by previous researchers., We found females to have more autonomic imbalance than males in diabetic and hypertensive population in our HR variability-based previous studies., There was double odds risk for prevalent central hypertension, brachial hypertension, and augmented aortic pulsation, but it was nonsignificant. In years to come, it gets further amplified, leading to incident hypertension more so in our female population with sedentary life, low body height, obesity, and coincidental diabetes.
We found higher aPWV with menopause than without menopause, in groups comparable for BMI (mean 27). However, [email protected], augmentation pressure, reflection magnitude, and total AS were comparable between groups. These parameters are related to small arteries and arterioles, while aPWV is measured from aorta. This hints toward earlier affection of aorta in cardiovascular aging with menopause compared to other arteries, as reported recently. Aortic PWV and not wave reflection parameters were significantly associated with a family history of hypertension, prevalent diabetes, and prevalent hypertension, as previously published. This points superiority of aPWV than wave reflection parameters in our middle-aged population.
Menopause–AS associations are supported by other studies with respect to PWV,,,, and wave reflection parameters,,, such as AIx. However, these were mainly tonometry-based studies, while Mobil-o-graph infers directly to aortic PWV. Contrastingly, to most studies,,,, we found lack of difference of AIx with or without menopause. However, this is in accordance with our normative study where we found AIx to be insignificantly different in all age groups from 15 to 65 years. Other reason can be the age, which was higher in most other studies than the current study group (mean age 52 in menopausal group). With exclusion of beyond 60-year female, we could highlight that aortic stiffness more than peripheral stiffness is affected in the initial few years of menopause. AS–menopause relationship can be explained by: (1) estrogen hypothesis, (2) androgen hypothesis, (3) sympathetic overactivity, (4) physical inactivity, (5) obesity (mean BMI >27-beyond obesity cut off for Asians, in both groups), (6) shorter height, and (7) aging effect (mean age – premenopausal group –45, postmenopausal group –52).
Obesity and metabolic syndrome are considered risk factors for hypertension, more than menopause or partly confounding it in perimenopausal group., However, we did not find BMI as a significant factor or predictor for CH and AS that underscores menopause as an independent cardiovascular disease risk factor. It can be due to high mean BMI and the fact that BMI is measure of general obesity. As previously noted, qualitative fat analysis is superior to general or quantitative measures for obesity, and this can be tested further using qualitative body fat analysis.
Age, BMI, and HR were not significant predictors of CH. Rather SBP and DBP were predictors of CH. One prospective study, in our affirmation, has reported SBP as a better parameter than DBP for assessing cardiovascular risk associated with aging. Strength of predictors increases in postmenopausal than premenopausal. This indicates that, with aging and withdrawal of hormonal support, they become significant. Aortic PWV was predicted mainly by age but still a large variance is not explained by age. Blood pressure, BMI, and HR were not major predictors of aPWV in either group. This reaffirms beyond blood pressure importance of aPWV. There is pressure dependency of local measures of AS, but aPWV is a measure of central stiffness, independent of bBPs that makes is more highlighted. Aortic PWV is stable, cumulative, potential, and reproducible parameter. [email protected] was mainly related to HR despite correction for HR. [email protected] did not differ between groups stratified by menopause and age, so it carries lesser value. Blood pressures were predictors of AS but with a greater magnitude for wave reflection parameters than aPWV. The prediction strength of BP increased from pre- to post-menopausal group and shifted from SBP to DBP.
Mid-life health is an issue, more so with increased life expectancy and early attainment of menopause. Cardiovascular health is determinant of overall health after middle age and in females. Blood pressure and HR are not direct surrogate markers and PWA overcomes this limitation by inferring centrally. With the availability of devices based on PWA, it can be used optimally to derive discrete conclusions. Our study reiterates menopause as a significant factor affecting AS and CH that needs further work. With this baseline data, further studies are needed with vertical follow-up, intervention, and in relation to biomarkers of aging.
Limitations of this study are small population with age difference between groups, recall bias regarding menopausal status, unavailability of biochemical parameters, and lack of follow-up.
| Conclusions|| |
In obese, predominantly sedentary midlife Gujarati women, AS and blood pressures, central more than peripheral, differ by menopause. Menopause is suggested to accelerate cardiovascular aging independent of BMI and age and may explain female disadvantage in mid-life for the same to some extent. PWA parameters can be further explored for causality and interventional studies relating menopause and cardiovascular health.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Mahajan A, Patni R, Gupta V. Menopause and cardiovascular disease. J Midlife Health 2019;10:55-6.
Lindroos AS, Langén VL, Kantola I, Salomaa V, Juhanoja EP, Sivén SS, et al
. Relation of blood pressure and organ damage: Comparison between feasible, noninvasive central hemodynamic measures and conventional brachial measures. J Hypertens 2018;36:1276-83.
Solanki JD, Mehta HB, Shah CJ. Pulse wave analysed cardiovascular parameters in young first degree relatives of hypertensives a case control study. J Res Med Sci 2018;23:72.
] [Full text]
Solanki JD, Mehta HB, Shah CJ. Aortic blood pressure and central hemodynamics measured by noninvasive pulse wave analysis in Gujarati normotensives. Int J Clin Exp Physiol 2018;5:75-80. [Full text]
Solanki JD, Mehta HB, Shah CJ. Aortic pulse wave velocity and augmentation [email protected]
measured by oscillometric pulse wave analysis in Gujarati nonhypertensives. Vasc Invest Ther 2018;1:50-5. [Full text]
Weiss W, Gohlisch C, Harsch-Gladisch C, Tölle M, Zidek W, van der Giet M. Oscillometric estimation of central blood pressure: Validation of the Mobil-O-Graph in comparison with the SphygmoCor device. Blood Press Monit 2012;17:128-31.
Ahuja M. Age of menopause and determinants of menopause age: A PAN India survey by IMS. J Midlife Health 2016;7:126-31.
Costa-Hong VA, Muela HC, Macedo TA, Sales ARK, Bortolotto LA. Gender differences of aortic wave reflection and influence of menopause on central blood pressure in patients with arterial hypertension. BMC Cardiovasc Disord 2018;18:123.
Harvey RE, Barnes JN, Hart EC, Nicholson WT, Joyner MJ, Casey DP. Influence of sympathetic nerve activity on aortic hemodynamics and pulse wave velocity in women. Am J Physiol Heart Circ Physiol 2017;312:H340-6.
Abbas SZ, Sangawan V, Das A, Pandey AK. Assessment of cardiovascular risk in natural and surgical menopause. Indian J Endocrinol Metab 2018;22:223-8.
Pandey S, Srinivas M, Agashe S, Joshi J, Galvankar P, Prakasam CP, et al
. Menopause and metabolic syndrome: A study of 498 urban women from western India. J Midlife Health 2010;1:63-9.
Sharma S, Aggarwal N, Joshi B, Suri V, Badada S. Prevalence of metabolic syndrome in pre- and post-menopausal women: A prospective study from apex institute of North India. J Midlife Health 2016;7:169-74.
Sherwood A, Park SB, Hughes JW, Blumenthal JA, Hinderliter A, Trivedi R, et al
. Cardiovascular hemodynamics during stress in premenopausal versus postmenopausal women. Menopause 2010;17:403-9.
Solanki JD, Munshi HB, Mehta HB, Shah CJ. Central hemodynamics and arterial stiffness in Gujarati diabetics not receiving any antihypertensive: A case-control study based on oscillometric pulse wave analysis. J Family Med Prim Care 2019;8:1352-8.
] [Full text]
Solanki JD, Mehta HB, Shah CJ. Oscillometric pulse wave analysis in newly diagnosed never treated Gujarati hypertensives. Vasc Invest Ther 2018;1:62-7. [Full text]
Tikhonoff V, Casiglia E, Gasparotti F, Spinella P. The uncertain effect of menopause on blood pressure. J Hum Hypertens 2019;33:421-8.
Hart EC, Charkoudian N, Joyner MJ, Barnes JN, Curry TB, Casey DP. Relationship between sympathetic nerve activity and aortic wave reflection characteristics in postmenopausal women. Menopause 2013;20:967-72.
Solanki JD, Basida SD, Mehta HB, Panjwani SJ, Gadhavi BP, Patel P. Impact of disease control and co-existing risk factors on heart rate variability in Gujarati Type 2 diabetics: An observational study. J Family Med Prim Care 2016;5:393-8.
] [Full text]
Solanki JD, Basida SD, Mehta HB, Panjwani SJ, Gadhavi BP. Comparative study of cardiac autonomic status by heart rate variability between under-treatment normotensive and hypertensive known Type 2 diabetics. Indian Heart J 2017;69:52-6.
Hickson SS, Nichols WW, Yasmin , McDonnell BJ, Cockcroft JR, Wilkinson IB, et al
. Influence of the central-to-peripheral arterial stiffness gradient on the timing and amplitude of wave reflections. Hypertens Res 2016;39:723-9.
Solanki JD, Mehta HB, Panjwani SJ, Munshi HB, Shah CJ. Central hemodynamics and arterial stiffness by oscillometric pulse-wave analysis in treated Gujarati euglycemic hypertensives: A case-control study. J Family Med Prim Care 2019;8:2047-54.
] [Full text]
Lambrinoudaki I, Kazani A, Armeni E, Rizos D, Augoulea A, Kaparos G, et al
. The metabolic syndrome is associated with carotid atherosclerosis and arterial stiffness in asymptomatic, nondiabetic postmenopausal women. Gynecol Endocrinol 2018;34:78-82.
Laucyte-Cibulskiene A, Vickiene A, Ryliskyte L, Badariene J, Rimsevicius L, Miglinas M. Should we calculate arterial stiffness gradient in middle-aged women with increased cardiovascular risk? Blood Press 2019;28:199-205.
Newson L. Menopause and cardiovascular disease. Post Reprod Health 2018;24:44-9.
Shapiro Y, Mashavi M, Luckish E, Shargorodsky M. Diabetes and menopause aggravate age-dependent deterioration in arterial stiffness. Menopause 2014;21:1234-8.
Solanki JD, Makwana AH, Mehta HB, Gokhale PA, Shah CJ. Body composition in Type 2 diabetes: Change in quality and not just quantity that matters. Int J Prev Med 2015;6:122.
] [Full text]
Miura K, Dyer AR, Greenland P, Daviglus ML, Hill M, Liu K, et al
. Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates: The Chicago heart association detection project in industry study. Hypertension 2001;38:232-7.
Zieff GH, Heffernan K, Stone K, Fryer S, Credeur D, Hanson ED, et al
. The pressure-dependency of local measures of arterial stiffness. J Hypertens 2019;37:956-63.
Maas AHEM. Maintaining cardiovascular health: An approach specific to women. Maturitas 2019;124:68-71.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]